Pfizer share news, announcements and annual reports
NSE: PFIZERBSE: 500680Pharmaceuticals & BiotechnologySmall Cap
Pfizer Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jul 1966 on BSE, Apr 1999 on NSE
Last close ₹3,687.80down ₹72.00 (1.92%)BSE ₹3,687.05
Share price at the NSE close on 30 Oct 2026. Previous close ₹3,759.80.
30 Oct: open ₹3,760.00, high ₹3,776.90, low ₹3,668.10
52-week range of traded prices to 30 Oct 2026
₹3,589.00Low, 23 Oct 2026₹5,346.00High, 30 Oct 2025
- Next results date: the board meets on 3 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹16,871 Cr327th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 22.95
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.01
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.03%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 17.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 21.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 17,12450.8% delivered
Pfizer dividends
26 filed, newest first.
May 2024
May 2023
Sep 2022
May 2022
20 May · Dividend
May 2021
27 May · Dividend
Jun 2020
Apr 2020
May 2019
May 2018
May 2017
May 2016
May 2015
5 May · Dividend
Board of Directors at its meeting held on May 05, 2015 has recommended a dividend of Rs.12.50/- per Equity share of Rs.10/- each (125%) for the financial year ended March 31, 2015. The said dividend, if declared at the ensuing Annual General Meeting of the Company, shall be paid on July 28, 2015.
Nov 2013
25 Nov · Dividend
Board of Directors of the Company at its meeting held on November 23, 2013 has approved the payment of Interim Dividend of Rs 360/- per equity share of Rs.10/- each (3600%) to the shareholders of the Company.25 Nov · Dividend
Interim Dividend will be paid on December 17, 2013.
Jul 2013
29 Jul · Dividend
Dividend recommended in the Board Meeting held on May 14, 2013 if declared at the Annual General Meeting, shall be paid on September 12, 2013.
May 2013
14 May · Dividend
Board of Directors at its meeting held on May 14, 2013 has recommended a normal dividend of Rs.12.50/- per Equity share of Rs.10 each (125%) and special Dividend of Rs. 20/- equity share of Rs. 10/- each (200%) on account of sale of animal health business aggregating to a total Dividend of Rs. 32.50/- per Equity share of Rs. 10/- each (325%) for the year ended March 31, 2013. The Said dividend, if declared at the ensuing Annual General Meeting of the Company, shall be paid on September 12, 2013.
May 2012
21 May · Dividend
Board of Directors at its meeting held on May 21, 2012 has recommended a dividend of Rs.12.50/- per Equity share of Rs.10 each (125%) for the year ended March 31, 2012. The Said dividend, if declared at the ensuing Annual General Meeting of the Company, shall be paid on August 16, 2012.
May 2011
3 May · Dividend
Board of Directors at its meeting held on May 03, 2011, has recommended a final dividend of Rs. 4.00 per Equity Share of Rs.10/- each (40%) for the 16 months period December 01, 2009 to March 31, 2011.The said final dividend shall be paid/dispatched on August 02, 2011.
Jan 2011
11 Jan · Dividend
Board of Directors of the Company at its meeting held on January 11, 2011, declared an Interim Dividend of Rs. 12.50/- per Equity share of Rs. 10 each (125%) for the current financial year ending March 31, 2011 i.e. 16 months period commencing from December 01, 2009 to March 31, 2011. The said Interim Dividend shall be paid / dispatched on January 31, 2011.
Feb 2010
25 Feb · Dividend
Pfizer Ltd. has informed the Exchange that the Board of Directors at its meeting held on February 25, 2010, recommended a Dividend of Rs. 12.50 per Equity Share of Rs.10/- each (125%) for the financial year ended November 30, 2009.
Jan 2009
30 Jan · Dividend
Pfizer Ltd. has informed the Exchange that the Board of Directors at its meeting held on January 30, 2009 recommended a dividend of Rs. 12.50 per Equity Share of Rs. 10/- each (125%) for the financial year ended November 30, 2008.
Feb 2008
25 Feb · Dividend
Pfizer Ltd. has informed the Exchange that the Board of Directors at its meeting held on February 25, 2008 recommended a total Dividend of Rs. 27.50 (275%) per Equity share of Rs. 10/- each, for the financial year ended November 30, 2007, being normal dividend of Rs. 12.50 (125%) per share and additional dividend of Rs. 15/- (150%) per equity share, in view of sale of four Consumer Healthcare Brands to Johnson & Johnson Limited.
Mar 2007
22 Mar · Dividend
Pfizer Ltd. has informed the Exchange on March 22, 2007 that : "At the Annual General Meeting of the Company held today the Shareholders approved the increase in final dividend payable by the Company for the Accounting Year 30th November, 2006 from Rs.12.50 per share (as recommended earlier by the Board) to Rs.22.50 per share."
Jan 2007
20 Jan · Dividend
Pfizer Ltd. has informed the Exchange that the Board of Directors of the Company at its Meeting held on January 20, 2007 has recommended a Dividend of Rs. 12.50 (125%) per equity share of Rs.10/- each for the Financial Year ended November 30, 2006.